Latest filing published 08 Jun 2022 for CytoDyn Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Chris P. Recknor: trading record in brief
Chris P. Recknor, listed as chief executive, appears in our data through filings on CytoDyn Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 6 August 2021 to 15 April 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 8 June 2022 came the latest disclosure, a share grant in CytoDyn Inc. Filings reach the SEC (Form 4) feed a median of 54 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Chris P. Recknor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,950 shares0Common StockSEC:0001104659-22-069300:0
- 19,384 shares0Common stockSEC:0000899243-21-032385:0
2 of 2 declarations